Results of General Meeting 5 May 2009
Results of General Meeting of Members ...
Convertible Notes Resolved
MTY has finalised an agreement with holders of MTY Convertible Notes ...
MTY Shareholder News October 2008
MTY Shareholder News
Removal of $1.5M potential liability
MTY and Cell Signals Inc., have signed an amendment to the IP Agreement
Analyst Report and Interactive Roadshow Released
... first online Interactive Investor Roadshow eKit ...
Midkine Test Validated
... Revenue Generating Veterinary Midkine Test Validated....
Midkine Strategy
...MTY completed its Midkine Commercial Developement Strategy...
Major US Patent Granted
...“Agents Comprising Midkine or an Inhibitor Thereof as Active Ingredient”...


Cellmid Ltd (CDY):

Last Price

ASX Announcement - Analyst Report and interactive Roadshow Released

Medical Therapies Limited (ASX:MTY) has launched the first online Interactive Investor Roadshow eKit™ to inform shareholders and the market in general of the progress of its product development programs.  

The roadshow material contains a video interview with Medical Therapies’ CEO, Maria Halasz, an independent research report prepared by leading research firm Wise-Owl, the company’s latest investor presentation update and a live contact link to the CEO and key business units on the company’s website. Investors may access the Interactive Roadshow eKit™ by visiting

http://medicaltherapies0901.interactiveinvestor.com.au 

 

© Cellmid Ltd
Share Trading Policy | Privacy | Contact Us
Web Developer Sydney
 Web design company
Cellmid Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@cellmid.com.au